C 745 (Glipizide Extended Release 5 mg)
Pill with imprint C 745 is Pink, Round and has been identified as Glipizide Extended Release 5 mg. It is supplied by Par Pharmaceutical, Inc.
Glipizide is used in the treatment of diabetes, type 2 and belongs to the drug class sulfonylureas. Risk cannot be ruled out during pregnancy. Glipizide 5 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for C 745
Glipizide Extended Release
- Imprint
- C 745
- Strength
- 5 mg
- Color
- Pink
- Size
- 9.00 mm
- Shape
- Round
- Availability
- Prescription only
- Drug Class
- Sulfonylureas
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Par Pharmaceutical, Inc.
- National Drug Code (NDC)
- 10370-0745
- Inactive Ingredients
-
lactose anhydrous,
butylated hydroxytoluene,
cellulose acetate,
silicon dioxide,
glyceryl monostearate,
hypromelloses,
magnesium stearate,
methacrylic acid - methyl methacrylate copolymer (1:2),
polyethylene glycol,
polysorbate 80,
propylene glycol,
sodium chloride,
sodium starch glycolate type A corn,
ferrosoferric oxide,
titanium dioxide,
triacetin,
FD&C Yellow No. 6,
FD&C Red No. 40
Note: Inactive ingredients may vary.
Related images for "C 745"
More about glipizide
- Side effects
- Drug interactions
- Dosage information
- During pregnancy or Breastfeeding
- Reviews (64)
- Patient tips
- Drug images
- Pricing & coupons
- En español
- Drug class: sulfonylureas
Patient resources
Other brands
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.